|
Zydus Lifesciences Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
119842.47 Cr.
|
P/BV
|
4.42
|
Book Value (Rs.)
|
269.43
|
|
52 Week High/Low (Rs.)
|
1182/836
|
FV/ML
|
1/1
|
P/E(X)
|
23.78
|
|
Bookclosure
|
24/07/2026
|
EPS (Rs.)
|
50.09
|
Div Yield (%)
|
0.08
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 26719.70 | 22573.80 | 19021.50 | 16877.80 | 14827.60 |
| Other Operating Revenues | 428.70 | 667.70 | 525.90 | 359.60 | 437.60 |
| Total Operating Revenues | 27148.40 | 23241.50 | 19547.40 | 17237.40 | 15265.20 |
| | | | | | |
| Other Income | 509.50 | 269.50 | 284.10 | 186.60 | 224.70 |
| Total Revenue | 27657.90 | 23511.00 | 19831.50 | 17424.00 | 15489.90 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 5109.60 | 4372.90 | 4580.50 | 4122.60 | 4042.90 |
| Purchase Of Stock-In Trade | 3070.50 | 2150.00 | 1897.90 | 1949.40 | 1864.60 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -887.50 | -184.90 | -250.20 | 238.10 | -362.30 |
| Employee Benefit Expenses | 4417.90 | 3680.60 | 3137.60 | 2765.60 | 2434.10 |
| Finance Costs | 438.90 | 165.90 | 81.20 | 129.90 | 127.00 |
| Depreciation And Amortisation Expenses | 1408.00 | 915.80 | 764.10 | 722.70 | 713.00 |
| Other Expenses | 6962.80 | 6164.40 | 4797.30 | 4301.80 | 3945.20 |
| Total Expenses | 20520.20 | 17264.70 | 15008.40 | 14230.10 | 12764.50 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 7137.70 | 6246.30 | 4823.10 | 3193.90 | 2725.40 |
| | | | | | |
| Exceptional Items | -516.60 | -219.60 | -14.20 | -604.20 | 112.70 |
| Profit/Loss Before Tax | 6621.10 | 6026.70 | 4808.90 | 2589.70 | 2838.10 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1379.50 | 2049.30 | 1492.60 | 690.40 | 441.50 |
| Deferred Tax | 215.20 | -637.40 | -515.10 | -102.60 | 70.20 |
| Total Tax Expenses | 1594.70 | 1411.90 | 977.50 | 587.80 | 511.70 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 5026.40 | 4614.80 | 3831.40 | 2001.90 | 2326.40 |
| | | | | | |
| Profit/Loss From Continuing Operations | 5026.40 | 4614.80 | 3831.40 | 2001.90 | 2326.40 |
| | | | | | |
| Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 29.20 | -7.00 | 2394.20 |
| Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 6.20 | -2.40 | 148.50 |
| Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 23.00 | -4.60 | 2245.70 |
| Profit/Loss For The Period | 5026.40 | 4614.80 | 3854.40 | 1997.30 | 4572.10 |
| | | | | | |
| Minority Interest | -83.50 | -147.10 | -113.30 | -131.60 | -131.00 |
| Share Of Profit/Loss Of Associates | 97.10 | 57.80 | 118.40 | 94.60 | 46.20 |
| Consolidated Profit/Loss After MI And Associates | 5040.00 | 4525.50 | 3859.50 | 1960.30 | 4487.30 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 50.09 | 44.97 | 38.14 | 19.30 | 43.83 |
| Diluted EPS (Rs.) | 50.09 | 44.97 | 38.14 | 19.30 | 43.83 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 1106.90 | 301.90 | 620.80 | 266.50 | 372.00 |
